Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Vascular dementia: pharmacological treatment approaches and perspectives Baskys A; Hou ACClin Interv Aging 2007[]; 2 (3): 327-35Vascular dementia is a common condition for which there are no effective approved pharmacological treatments available. Absence of effective treatments creates a difficult situation for those suffering from the disease, their caregivers, and healthcare providers. This review will address our current understanding of the mechanisms of nerve cell damage due to ischemia and summarize available clinical trial data on several commonly used compounds including memantine, donepezil, galantamine, rivastigmine, nimodipine, hydergine, nicergoline, CDP-choline, folic acid, as well as such nonpharmacological approaches as validation therapy.|Brain Ischemia/*complications/drug therapy/metabolism[MESH]|Cholinesterase Inhibitors/therapeutic use[MESH]|Cognition/drug effects[MESH]|Dementia, Vascular/*drug therapy/etiology/metabolism[MESH]|Excitatory Amino Acid Antagonists/therapeutic use[MESH]|Glutamic Acid/metabolism[MESH]|Humans[MESH]|Nerve Degeneration/*complications/drug therapy/etiology/metabolism[MESH]|Neuroprotective Agents/pharmacology/*therapeutic use[MESH]|Nootropic Agents/pharmacology/*therapeutic use[MESH]|Receptors, Glutamate/drug effects/metabolism[MESH]|Treatment Outcome[MESH] |